Here you are inform about ALS newsand the IPG actions
Dr. Marka van Blitterswijk (M.D., Ph.D.) is the winner of the 9th Paulo Gontijo International Award in Medicine. Learn more about your research.
The 9th Paulo Gontijo International Award in Medicine was awarded to Dr. Marka van Blitterswijk (M.D., Ph.D.), assistant professor of neuroscience at the Mayo Clinic (Jacksonville, FL, USA).
The award aims to encourage and recognize research on amyotrophic lateral sclerosis (ALS), the third most frequent neurodegenerative disease in the world.
Dr. Marka van Blitterswijk (M.D., Ph.D.) is an Assistant Professor of Neuroscience at Mayo Clinic (Jacksonville, FL, USA). She tries to understand why there is so much variability amongst patients with ALS, including in the age at which the first symptoms occur, presence of dementia, disease progression, and survival. Most of her patient-oriented research has focused on one particular cause of ALS: a mutation in a gene called C9ORF72. Together with her colleagues, she has examined specific candidates, but she is also using more sophisticated large-scale approaches, to find abnormalities in our DNA and RNA that might account for this variability. These abnormalities could point to promising disease modifiers, biomarkers, and/or therapeutic targets, translating her research into clinical practice. Importantly, Dr. Van Blitterswijk’s work emphasizes that the explanation is much more complex than previously thought, and that an intricate combination of factors is responsible for the observed variability.
Dr. Van Blitterswijk's work emphasizes that the explanation is much more complex than previously thought and that an intricate combination of factors is responsible for the observed variability.
The judgment of the PG Medical Award was made by the International Jurors of the IPG, composed of scientific authorities, both Brazilian and international, involved in the research of Amyotrophic Lateral Sclerosis. The award is supported by the International Alliance of ELA / DNM, MND Association and the European Network for the Cure of ALS - (Encals) and is the only one delivered by a Brazilian entity to the international scientific community that researches the cause and cure of SHE.
The $ 20,000 prize and a gold medal will be presented at the opening of the 28th International ELA / DNM Symposium, to be held in Boston, United States, on December 8. The Symposium is organized by the Association of Neuromuscular Diseases and at the time, Dr. Marka will present results of her work.
IPG is proud of its previous year's award recipients who continue to participate in important projects impacting international research that seek the cause and cure of ALS. The PG award is also a way of recognizing IPG's creator, Paulo Gontijo, who is affected by the disease and tireless in the search for his cure.